CIK 0001770069 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
MapLight Therapeutics, Inc.
Sign in to watch- Ticker
- MPLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 832163243
- Phone
- 650-839-4360
- Business address
- 800 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- Alvarado Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,256,232
- in 7 filings, $193K under 10b5-1 plans
Net −$1,256,232. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Kroeger Christopher A. −$595K Chief Executive Officer sold 6% of stake
- Hanson Kristopher −$266K General Counsel sold 17% of stake
- Foff Erin Pennock −$124K Chief Medical Officer sold 5% of stake
- Kreitzer Anatol −$96K Chief Discovery Officer sold 7% of stake
- Lillie James Woodruff −$93K Chief Scientific Officer sold 5% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-07 | Lillie James Woodruff Chief Scientific Officer | Sale 10b5-1 | −721 | $28.28 | $20K | 242,729 |
| 2026-05-07 | Kroeger Christopher A. Chief Executive Officer | Sale 10b5-1 | −14,880 | $28.47 | $424K | 1,565,940 |
| 2026-05-07 | Kroeger Christopher A. Chief Executive Officer | Sale 10b5-1 | −5,220 | $29.15 | $152K | 1,560,720 |
| 2026-05-06 | Setia Vishwas Chief Financial Officer | Sale 10b5-1 | −8,496 | $28.04 | $238K | 358,324 |
| 2026-05-06 | Setia Vishwas Chief Financial Officer | Sale 10b5-1 | −2,068 | $29.07 | $60K | 356,256 |
| 2026-05-06 | Foff Erin Pennock Chief Medical Officer | Sale 10b5-1 | −8,152 | $28.04 | $229K | 366,397 |
| 2026-05-06 | Foff Erin Pennock Chief Medical Officer | Sale 10b5-1 | −15,900 | $29.13 | $463K | 350,497 |
| 2026-05-06 | Lillie James Woodruff Chief Scientific Officer | Sale 10b5-1 | −8,390 | $28.04 | $235K | 259,871 |
| 2026-05-06 | Lillie James Woodruff Chief Scientific Officer | Sale 10b5-1 | −16,421 | $29.13 | $478K | 243,450 |
| 2026-05-06 | Kroeger Christopher A. Chief Executive Officer | Sale 10b5-1 | −8,098 | $28.04 | $227K | 1,596,423 |
| 2026-05-06 | Kroeger Christopher A. Chief Executive Officer | Sale 10b5-1 | −15,603 | $29.13 | $455K | 1,580,820 |
| 2026-05-05 | Setia Vishwas Chief Financial Officer | Sale 10b5-1 | −9,935 | $28.12 | $279K | 367,788 |
| 2026-05-05 | Setia Vishwas Chief Financial Officer | Sale 10b5-1 | −968 | $29.00 | $28K | 366,820 |
| 2026-05-05 | Foff Erin Pennock Chief Medical Officer | Sale 10b5-1 | −9,645 | $28.12 | $271K | 375,480 |
| 2026-05-05 | Foff Erin Pennock Chief Medical Officer | Sale 10b5-1 | −931 | $29.00 | $27K | 374,549 |
| 2026-05-05 | Lillie James Woodruff Chief Scientific Officer | Sale 10b5-1 | −10,132 | $28.12 | $285K | 269,224 |
| 2026-05-05 | Lillie James Woodruff Chief Scientific Officer | Sale 10b5-1 | −963 | $29.00 | $28K | 268,261 |
| 2026-05-05 | Kroeger Christopher A. Chief Executive Officer | Sale 10b5-1 | −9,544 | $28.12 | $268K | 1,605,449 |
| 2026-05-05 | Kroeger Christopher A. Chief Executive Officer | Sale 10b5-1 | −928 | $29.00 | $27K | 1,604,521 |
| 2026-05-04 | Setia Vishwas Chief Financial Officer | Sale 10b5-1 | −4,803 | $27.36 | $131K | 387,824 |
Page 6 of 12 · 239 trades